secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2025-07-07T23:59:59+00:00
Accession:  0001104659-25-066091
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 2.05, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics cuts 51% of workforce; CFO and CDO to depart
-----------------------------------------------------------------

- Board approved reduction in force of ~51% of employees; expects $3.7M in severance costs.
- CFO Morgan Conn to depart effective July 11; SVP Finance Douglas Carr named interim principal financial officer.
- Chief Development Officer Adrienne Farid to depart effective July 31.
- Workforce reduction substantially complete by end of Q3 2025; company focusing on highest-potential programs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465925066091/0001104659-25-066091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465925066091/tm2519717d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-066091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer